DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,548,731 | -12.3% | 10,273 | -15.2% | 0.07% | -11.8% |
| Q2 2023 | $2,906,400 | -5.3% | 12,110 | -0.5% | 0.08% | -14.6% |
| Q1 2023 | $3,068,587 | -52.8% | 12,175 | -50.3% | 0.09% | -6.3% |
| Q4 2022 | $6,500,136 | +105.4% | 24,490 | +99.9% | 0.10% | -6.9% |
| Q3 2022 | $3,164,000 | +1.9% | 12,250 | 0.0% | 0.10% | +9.7% |
| Q2 2022 | $3,106,000 | -14.1% | 12,250 | -0.6% | 0.09% | +2.2% |
| Q1 2022 | $3,615,000 | -11.4% | 12,325 | -0.6% | 0.09% | -6.2% |
| Q4 2021 | $4,080,000 | +8.1% | 12,402 | 0.0% | 0.10% | -1.0% |
| Q3 2021 | $3,776,000 | +13.5% | 12,402 | 0.0% | 0.10% | +10.1% |
| Q2 2021 | $3,328,000 | +19.2% | 12,402 | +0.0% | 0.09% | +3.5% |
| Q1 2021 | $2,791,000 | +0.3% | 12,400 | -1.0% | 0.09% | -6.5% |
| Q4 2020 | $2,782,000 | +0.0% | 12,525 | -3.0% | 0.09% | -9.8% |
| Q3 2020 | $2,781,000 | +21.8% | 12,915 | 0.0% | 0.10% | +20.0% |
| Q2 2020 | $2,284,000 | +27.7% | 12,915 | 0.0% | 0.08% | +6.2% |
| Q1 2020 | $1,788,000 | -15.1% | 12,915 | -5.8% | 0.08% | +14.3% |
| Q4 2019 | $2,105,000 | -1.5% | 13,715 | -7.3% | 0.07% | -6.7% |
| Q3 2019 | $2,138,000 | -3.0% | 14,800 | -4.1% | 0.08% | -2.6% |
| Q2 2019 | $2,205,000 | +8.3% | 15,425 | 0.0% | 0.08% | +5.5% |
| Q1 2019 | $2,036,000 | +16.9% | 15,425 | -8.7% | 0.07% | +4.3% |
| Q4 2018 | $1,741,000 | -5.1% | 16,888 | 0.0% | 0.07% | +20.7% |
| Q3 2018 | $1,835,000 | +8.6% | 16,888 | -1.3% | 0.06% | +1.8% |
| Q2 2018 | $1,689,000 | -0.2% | 17,113 | -1.0% | 0.06% | 0.0% |
| Q1 2018 | $1,692,000 | +5.4% | 17,285 | -0.0% | 0.06% | +7.5% |
| Q4 2017 | $1,605,000 | +8.2% | 17,288 | -0.1% | 0.05% | +8.2% |
| Q3 2017 | $1,484,000 | -14.1% | 17,303 | -15.5% | 0.05% | -15.5% |
| Q2 2017 | $1,728,000 | -3.8% | 20,472 | -2.6% | 0.06% | -7.9% |
| Q1 2017 | $1,797,000 | +9.8% | 21,009 | -0.1% | 0.06% | +6.8% |
| Q4 2016 | $1,637,000 | -0.7% | 21,034 | 0.0% | 0.06% | 0.0% |
| Q3 2016 | $1,649,000 | -22.7% | 21,034 | -0.3% | 0.06% | -21.3% |
| Q2 2016 | $2,132,000 | +5.5% | 21,106 | -0.9% | 0.08% | +5.6% |
| Q1 2016 | $2,020,000 | +1.8% | 21,291 | -0.3% | 0.07% | +4.4% |
| Q4 2015 | $1,984,000 | +5.3% | 21,363 | -3.4% | 0.07% | +19.3% |
| Q3 2015 | $1,884,000 | -10.3% | 22,109 | -9.9% | 0.06% | +3.6% |
| Q2 2015 | $2,100,000 | +0.8% | 24,534 | 0.0% | 0.06% | +5.8% |
| Q1 2015 | $2,083,000 | -1.0% | 24,534 | 0.0% | 0.05% | +2.0% |
| Q4 2014 | $2,103,000 | +12.3% | 24,534 | -0.4% | 0.05% | +15.9% |
| Q3 2014 | $1,872,000 | -5.8% | 24,634 | -2.4% | 0.04% | -2.2% |
| Q2 2014 | $1,987,000 | +2.3% | 25,239 | -2.6% | 0.04% | 0.0% |
| Q1 2014 | $1,943,000 | -3.2% | 25,905 | -0.3% | 0.04% | -8.2% |
| Q4 2013 | $2,007,000 | +10.2% | 25,995 | -1.0% | 0.05% | +2.1% |
| Q3 2013 | $1,821,000 | +9.5% | 26,269 | 0.0% | 0.05% | +6.7% |
| Q2 2013 | $1,663,000 | – | 26,269 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |